You just read:

MabVax Therapeutics to Present Phase I Clinical Trial Results of MVT-5873 for the Treatment of Advanced Pancreatic Cancer in Poster Presentation at the 2017 ASCO Annual Meeting

News provided by

MabVax Therapeutics Holdings, Inc.

May 25, 2017, 07:05 ET